OptimizeRx Corporation (OTCMKTS:OPRX) Getting Touted Again

[[tagnumber 0]][[tagnumber 1]]The stock of OptimizeRx Corporation (OTCMKTS:OPRX) rarely sees a lot of trading, but has been doing fairly good when it comes to price lately. The ticker ascended above the $1 per share mark in the second half of last month and nagged to keep the gains, despite several red sessions.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]][[tagnumber 6]]OPRX[[tagnumber 7]] doesn’t really command a significant market cap which makes it a pretty decent choice. The numbers that the company has in its books are also good for an OTC entity. Here is just an example of some of the ones of prime interest that were contained in the latest quarterly report.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 11]] [[tagnumber 12]]cash: $3.64 million[[tagnumber 13]] [[tagnumber 12]]current assets: $5.64 million[[tagnumber 13]] [[tagnumber 12]]total liabilities: $2.27 million[[tagnumber 13]] [[tagnumber 12]]quarterly revenues: $1.7 million[[tagnumber 13]] [[tagnumber 12]]quarterly net loss: $157 thousand[[tagnumber 13]] [[tagnumber 22]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]It appears that [[tagnumber 6]]OPRX[[tagnumber 7]] is doing pretty good when you compare their balance sheet to those of other OTC entities that command far bigger market caps. Still, the company stock is quite illiquid, so making a profit betting on it might be a bit tricky.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Last week ended with a 9.17% gain for [[tagnumber 6]]OPRX[[tagnumber 7]] and we saw the ticker close Friday’s session with a price of $1.31. The volume was well above the average, but the 122 thousand shares that changed their owners generated only $158 thousand in daily trade value.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]So far, we see the ticker hesitating in today’s trading. Doing your due diligence and weighing out the risks before putting any money on the line is a must.[[tagnumber 2]]